Clinical Journal of Gastroenterology

, Volume 7, Issue 5, pp 429–433 | Cite as

Spontaneous rupture of a hepatic angiomyolipoma: Report of a case

  • Hideki Aoki
  • Takashi Arata
  • Toshiaki Morihiro
  • Nobuhiko Kanaya
  • Sho Takeda
  • Kenta Sui
  • Kunitoshi Shigeyasu
  • Koh Katsuda
  • Kohji Tanakaya
  • Hitoshi Takeuchi
Case Report

Abstract

A 70-year-old female experienced sudden onset of back pain on the right side and was admitted to our hospital in December 2010. Abdominal computed tomography revealed an S7 hepatic mass measuring 7 cm in diameter accompanied by a subcapsular hematoma. Emergency angiography confirmed the diagnosis of a ruptured hepatic mass, and hemostasis was carried out by embolization of A8 and A7 of the liver. A right hepatic lobectomy was carried out 39 days following transarterial embolization. Although almost all aspects of the tumor were necrotic, residual tumor cells stained positive for HMB-45, and negative for α-SMA, S-100, CD 34, c-kit, CAM 5.2, and hepatocytes. The MIB-1 index was 2 %. Pathological diagnosis was hepatic angiomyolipoma (HAML). The patient has shown no signs of recurrence at 42 months following surgery. Here, we report on this case of spontaneous HAML rupture and discuss therapeutic strategies for HAML and ruptured hepatic tumors.

Keywords

Hepatic angiomyolipoma Rupture HMB-45 

References

  1. 1.
    Ishlak KG. Mesenchymal tumors of the liver. In: Okuda K, Peters RL, editors. Hepatocellular carcinoma. New York: Wiley; 1976. p. 247–307.Google Scholar
  2. 2.
    Nguyen TT, Gorman B, Shields D, Goodman Z. Malignant hepatic angiomyolipoma: report of a case and review of literature. Am J Surg Pathol. 2008;32:793–978.PubMedCrossRefGoogle Scholar
  3. 3.
    Huber C, Treutner KH, Steinau G. Ruptured hepatic angiolipoma in tuberous sclerosis complex. Langenbecks Arch Chir. 1996;381:7–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Zhou YM, Li B, Xu F, Wang B, Li DQ, Zhang XF, Liu P, Y JM. Clinical features of hepatic angiomyolipoma. Hepatobiliary Pancreat Dis Int. 2008;7:284–7.PubMedGoogle Scholar
  5. 5.
    Du S, Li Y, Mao Y, Sang X, Lu X, Wang W, Zhang Q, Xue H, Yang X, Li S, Chi T, Zhong S, Huang J. Diagnosis and treatment of hepatic angiomyolipoma. Hepatobiliary Surg Nutr. 2012;1:19–24.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Oesterling JE, Fishman EK, Goldman SM, Marshall EF. The management of renal angiomyolipomas in patients with tuberous sclerosis. J Urol. 1994;152:35–8.Google Scholar
  7. 7.
    Guidi G, Catalano O, Rotondo A. Spontaneous rupture of a hepatic angiomyolipoma: CT findings and literature review. Eur Radiol. 1997;7:335–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Chang ZG, Zhang JM, Ying JQ, Ge YP. Characteristics and treatment strategy of hepatic angiomyolipoma: a series of 94 patients collected from four institutions. J Gastrointest Liver Dis. 2011;20:65–9.Google Scholar
  9. 9.
    Kamimura K, Nomoto M, Aoyagi Y. Hepatic angiomyolipoma: diagnostic findings and management. Int J Hepatol. 2012;2012:410781.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Martignoni G, Pea M, Reghellin D, Zamboni G, Bonetti F. PEComas: the past, the present and the future. Virchows Arch. 2008;452:119–32.PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Aoki T, Kokudo N, Matsuyama Y, Izumi N, Ichida T, Kudo M, Ku Y, Sakamoto M, Nakashima O, Matsui O, Makuuchi M, Liver Cancer Study Group of Japan. Prognostic impact of spontaneous tumor rupture in patients with hepatocellular carcinoma: an analysis of 1160 cases from a nationwide survey. Ann Surg. 2014;259:532–42.PubMedCrossRefGoogle Scholar
  12. 12.
    Deneve JL, Pawlik TM, Cunningham S, Clary B, Reddy S, Scoggins CR, Martin RCG, D’Angelica M, Stanley CA, Choti MA, Jarnagin WR, Schulick RD, Kooby DA. Liver cell adenoma: a multicentric analysis of risk factor for rupture and malignancy. Am Surg Oncol. 2009;16:640–8.CrossRefGoogle Scholar
  13. 13.
    Schnelldorfer T, Ware AL, Smoot R, Schleck CD, Harmsen WS, Nagorney DM. Management of giant hemangioma of the liver: resection versus observation. J Am Coll Surg. 2010;211:724–30.PubMedCrossRefGoogle Scholar
  14. 14.
    Cho SW, Marsh W, Steel J, Holloway SE, Heckman JT, Ochoa ER, Geller DA, Gamblin TC. Surgical management of hepatocellular adenoma: take it or leave it? Ann Surg Oncol. 2008;15:2795–803.PubMedCrossRefGoogle Scholar
  15. 15.
    Bissler JJ, Kingswood JC, Radzikowska E, Zonnenberg BA, Frost M, Belousova E, Sauter M, Nonomura N, de Vries PJ, Whittemore VH, Chen D, Sahmoud T, Shah G, Lincy J, Lebwohl D, Budde K. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2013;381(9869):817–24.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2014

Authors and Affiliations

  • Hideki Aoki
    • 1
  • Takashi Arata
    • 1
  • Toshiaki Morihiro
    • 1
  • Nobuhiko Kanaya
    • 1
  • Sho Takeda
    • 1
  • Kenta Sui
    • 1
  • Kunitoshi Shigeyasu
    • 1
  • Koh Katsuda
    • 1
  • Kohji Tanakaya
    • 1
  • Hitoshi Takeuchi
    • 1
  1. 1.Department of SurgeryNational Hospital Iwakuni Clinical CenterIwakuniJapan

Personalised recommendations